A Phase 1 Dose-escalation and Expansion Study of CUE-101, Given As Monotherapy in 3rd Line and in Combination with Pembrolizumab in 1st Line Recurrent/Metastatic (R/M) HPV16+ Head and Neck Cancer Patients
A. Colevas, C.H. Chung, D. Adkins, C. Rodriguez, J.C. Park, M. Gibson, A. Sukari, B. Burtness, F. Johnson, R.A. Julian, N. Saba, F. Worden, L. Dunn, T. Seiwert, R. Jotte, R. Haddad, N. Gabrail, J. Bauman, S. Margossian, S. Pai
{"title":"A Phase 1 Dose-escalation and Expansion Study of CUE-101, Given As Monotherapy in 3rd Line and in Combination with Pembrolizumab in 1st Line Recurrent/Metastatic (R/M) HPV16+ Head and Neck Cancer Patients","authors":"A. Colevas, C.H. Chung, D. Adkins, C. Rodriguez, J.C. Park, M. Gibson, A. Sukari, B. Burtness, F. Johnson, R.A. Julian, N. Saba, F. Worden, L. Dunn, T. Seiwert, R. Jotte, R. Haddad, N. Gabrail, J. Bauman, S. Margossian, S. Pai","doi":"10.1016/j.ijrobp.2024.01.192","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"46 18","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology*Biology*Physics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2024.01.192","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
